These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14076133)

  • 1. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES.
    HELLEMANS J; VORLAT M; VERSTRAETE M
    Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133
    [No Abstract]   [Full Text] [Related]  

  • 2. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 3. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 4. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT.
    PYOERAELAE K
    Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207
    [No Abstract]   [Full Text] [Related]  

  • 5. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON PROCONVERTIN (FACTOR VII) II. PURIFICATION.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():101-7. PubMed ID: 14124442
    [No Abstract]   [Full Text] [Related]  

  • 8. ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE].
    SOULIER JP; BLATRIX C; STEINBUCH M
    Presse Med (1893); 1964 Apr; 72():1223-8. PubMed ID: 14134215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of synthetic vitamin K1 on prothrombin, factor VII complex and factor IX in premature infants].
    YOSHIDA K; MORII N; KANMI M; YOSHIDA K
    Paediatr Jpn; 1963 Jun; 67():373-8. PubMed ID: 14002672
    [No Abstract]   [Full Text] [Related]  

  • 10. OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.
    PAPAHADJOPOULOS D; HANAHAN DJ
    Biochim Biophys Acta; 1964 Aug; 90():436-9. PubMed ID: 14220741
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 12. HYPERCOAGULABILITY OF BLOOD AFTER BURN TRAUMA IN RATS. A PRELIMINARY REPORT.
    ARTURSON G; WALLENIUS G
    Acta Chir Scand; 1964 Oct; 128():340-5. PubMed ID: 14211288
    [No Abstract]   [Full Text] [Related]  

  • 13. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 15. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 16. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 17. NATURE OF PROTHROMBIN BIOSYNTHESIS: PREPROTHROMBINAEMIA IN VITAMIN K-DEFICIENCY.
    HEMKER HC; VELTKAMP JJ; HENSEN A; LOELIGER EA
    Nature; 1963 Nov; 200():589-90. PubMed ID: 14082242
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTICOAGULANT THERAPY--BOON OR BANE?
    CELANDER DR; CELANDER E; MARTIN CG
    J Am Osteopath Assoc; 1964 Dec; 64():359-65. PubMed ID: 14233113
    [No Abstract]   [Full Text] [Related]  

  • 19. Deficiencies in Stuart (Prower) factor, plasma thromboplastin component, prothrombin, and factor VII, due to malabsorption of vitamin K.
    HOFFMAN GC; HEWLETT JS
    Cleve Clin Q; 1959 Jan; 26(1):15-23. PubMed ID: 13639251
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.